MRTLE2 Study vs EpilepsyDaily
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MRTLE2 Study
Read full descriptionHide full description
This app is an advanced electronic patient diary targeted specifically for epilepsy patients who are having a severe case of epilepsy. This app allows patients to enter data about their seizures, side effects and guides them in providing a very detailed and granular information that helps assessing their condition.
EpilepsyDaily
Read full descriptionHide full description
EpilepsyDaily helps you to gain an overview of the connections between epilepsy and everyday things. For example, different foods can have an impact on your well-being or promote migraines. Too much sleep deprivation can promote seizures and a perceived aura can be an indication of excessive stress.
Screenshots
Verdict
The clearest difference is device support: MRTLE2 Study at 2 against EpilepsyDaily's —. MRTLE2 Study also leads on iOS requirement (13.0 vs 15.0). On price and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | MRTLE2 Study | EpilepsyDaily |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 5 weeks | — |
| Ads | No | — |
| In-app purchases | No | No |
| Devices | iPhone, iPod — better | — |
| Requires iOS | 13.0 — better | 15.0 |
| Further details — not scored | ||
| Size | 9 MB | 1 MB |
| Age rating | 17+ | 4+ |
| Developer | Irody Inc. | Dennis Steinhauser |
In-app purchases
MRTLE2 Study
No in-app purchases
EpilepsyDaily
No in-app purchases
